31,700 results match your criteria Lymphoma Bone


Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients.

Eur Radiol 2019 Feb 14. Epub 2019 Feb 14.

Department of Radiology, Institut Bergonié, Comprehensive Cancer Center, 229, cours de l'Argonne, F-33000, Bordeaux, France.

Objectives: SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a recently identified aggressive subtype of sarcoma. The aim of this study was to characterize the CT imaging features of SMARCA4-DTS.

Methods: From June 2011 to May 2017, 21 adult patients with histologically proven SMARCA4-DTS were identified in the radiological database of 2 French sarcoma reference centers with at least one chest CT scan available. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-019-06017-xDOI Listing
February 2019

Extreme Hypoglycaemia in Anaplastic Large Cell Lymphoma.

Eur J Case Rep Intern Med 2017 27;4(2):000510. Epub 2017 Mar 27.

Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.

Introduction: Hypoglycaemia associated with non-islet cell tumours (NICTH) is a rare entity in patients with extra-pancreatic malignancies, mostly attributed to large mesenchymal or epithelial tumours. Anaplastic large cell lymphoma has not previously been associated with NICTH, making this the first publication of such a report.

Patient And Methods: A 22-year-old, non-diabetic patient was admitted to our department with malaise, itching, night sweats and weight loss. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12890/2016_000510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346898PMC

Intravascular Lymphoma as an Uncommon Cause of Anasarca.

Eur J Case Rep Intern Med 2016 29;3(5):000424. Epub 2016 Jun 29.

Fifth Department of Medicine, Evangelismos General Hospital, Athens, Greece.

Objectives: To report a case of intravascular lymphoma (IVL) in a Caucasian patient who presented with anasarca as his sole clinical sign.

Material And Methods: A man presented with anasarca-type oedema and fatigue. After excluding heart failure, hepatic cirrhosis, nephrotic syndrome, hypothyroidism, AL-amyloidosis and adverse drug reaction which can all cause oedema, we turned our attention to capillary permeability disorders. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12890/2016_000424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346965PMC

Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels.

J Exp Clin Cancer Res 2019 Feb 12;38(1):73. Epub 2019 Feb 12.

Department of Blood Transfusion, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Panfu Rd No.1, Yuexiu District, Guangzhou, 510180, Guangdong, China.

Background: The drug-resistance and relapse of diffuse large B-cell lymphoma (DLBCL), which are related to mesenchymal stem cells (MSCs), have become increasingly common. However, the underlying mechanisms remain elusive.

Methods: CCK 8 assay, colony formation assay, and xenograft mouse model were used to investigate the effects of hBMSCs on DLBCL growth. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-019-1081-7DOI Listing
February 2019

Extranodal diffuse large B cell lymphoma of maxillary sinus presenting as a palatal ulcer.

BMJ Case Rep 2019 Feb 9;12(2). Epub 2019 Feb 9.

Department of Oral Surgery, Amrita School of Dentistry, AIMS Campus, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.

A multitude of disease processes ranging from periodontitis to malignancies can lead to formation of solitary ulcer on the palate. Hence solitary ulcers of palate can often be a challenging one to diagnose. We report an interesting case of a diffuse large B cell lymphoma of the maxillary sinus which perforated the palatal bone and presented clinically as a palatal ulcer. Read More

View Article

Download full-text PDF

Source
http://casereports.bmj.com/lookup/doi/10.1136/bcr-2018-22860
Publisher Site
http://dx.doi.org/10.1136/bcr-2018-228605DOI Listing
February 2019
3 Reads

Breast cancer after multiple myeloma treatment.

Authors:
Ahmet Gulmez

Curr Probl Cancer 2019 Feb 1. Epub 2019 Feb 1.

Inonu Univercity Turgut Ozal Medical Center, Malatya/Türkiye, Malatya, Turkey. Electronic address:

Breast cancer is the most common cancer in women. In addition, it is the second leading cause of death after lung cancer. The prevalence of epidemiological studies in previous studies is 22%-26%. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2019.01.004DOI Listing
February 2019

[Clinical Significance of Detecting the Erythrocyte Life Expectancy in Patients with Malignant Lymphoma Complicated with Anemia].

Zhongguo Shi Yan Xue Ye Xue Za Zhi 2019 Feb;27(1):80-85

Department of Hematology, Peking Union Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730,

Objective: To investigate the clinical value of erythrocyte life span in the diagnosis and treatment of lymphoma patients with anemia.

Methods: The clinical data of 45 patients with lymphoma diagnosed by Department of Hematology in Beijing Union Hospital from January 2017 to June 2017 were collected. The life of erythrocytes was detected by alveolar gas CO test. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7534/j.issn.1009-2137.2019.01.013DOI Listing
February 2019
1 Read

[Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma].

Zhongguo Shi Yan Xue Ye Xue Za Zhi 2019 Feb;27(1):52-60

Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy in Tianjin, Tianjin's Clinical Research Center for Cancer,Tianjin 300060, China.E-mail:

Objective: To compare the prognostic value of different staging systems in primary intestinal diffuse large B cell lymphoma(PI-DLPCL), and their correlation with clinicopathological characteristics,treatment and prognosis of PI-DLBCL.

Methods: A total of 68 patients with PI-DLBCL were recruited from January 2009 to July 2017. All the patients underwent staging by using TNM, Lugano, Blackledge and Musshoff system, survival curves for the PI-DLBCL patients were plotted using the Kaplan-Meier method and were judged by the log-rank test. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7534/j.issn.1009-2137.2019.01.009DOI Listing
February 2019
2 Reads

Primary pulmonary lymphoma in children.

Orphanet J Rare Dis 2019 Feb 8;14(1):35. Epub 2019 Feb 8.

Department of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, Nanlishi Road 56, Xicheng District, Beijing, China.

Background: Primary pulmonary lymphoma (PPL) is a rare disease, especially in children. We analyse the clinical features of PPL in 4 children to strengthen a understanding of it.

Results: We reported a case series of 4 pediatric patients with PPLs including three diffuse large B-cell lymphomas and one natural killer-T cell lymphoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-019-1009-5DOI Listing
February 2019
1 Read

Exosomes Derived From Bone Mesenchymal Stem Cells Ameliorate Early Inflammatory Responses Following Traumatic Brain Injury.

Front Neurosci 2019 24;13:14. Epub 2019 Jan 24.

Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Traumatic brain injury (TBI) is a leading cause of mortality and disability worldwide. Although treatment guidelines have been developed, no best treatment option or medicine for this condition exists. Recently, mesenchymal stem cells (MSCs)-derived exosomes have shown lots of promise for the treatment of brain disorders, with some results highlighting the neuroprotective effects through neurogenesis and angiogenesis after TBI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnins.2019.00014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354067PMC
January 2019

CD4 TSCMs in the Bone Marrow Assist in Maturation of Antibodies against Influenza in Mice.

Mediators Inflamm 2019 10;2019:3231696. Epub 2019 Jan 10.

Shenzhen Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen 518001, China.

The bone marrow (BM) is not only a reservoir of hematopoietic stem cells but a repository of immunological memory cells. Further characterizing BM-resident memory T cells would be helpful to reveal the complicated relationship between the BM and immunological memory. In this study, we identified CD122 stem cell antigen-1 (Sca-1) B cell lymphoma 2 (Bcl-2) CD4 stem cell-like memory T cells (TSCMs) as a distinct memory T cell subset, which preferentially reside in the BM, where they respond vigorously to blood-borne antigens. Read More

View Article

Download full-text PDF

Source
https://www.hindawi.com/journals/mi/2019/3231696/
Publisher Site
http://dx.doi.org/10.1155/2019/3231696DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348795PMC
January 2019
2 Reads

Diffuse Large B-Cell Lymphoma Relapsing in Leukaemic Phase Presenting as Acute Leukaemia.

Clin Med Insights Blood Disord 2019 15;12:1179545X18821160. Epub 2019 Jan 15.

Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, New Delhi, India.

Diffuse large B-cell lymphoma (DLBCL) accounts for 30% to 40% of the newly diagnosed adult non-Hodgkin lymphomas, but rarely presents in leukaemic phase. Here in, we report a case of DLBCL presenting in leukaemic phase and masquerading as acute leukaemia. A 28-year-old woman presented to our outpatient department with complaints of fever for 1 week. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1179545X18821160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343450PMC
January 2019

Cryoglobulinemia: an update in 2019.

Joint Bone Spine 2019 Feb 4. Epub 2019 Feb 4.

Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMR S 959, Immunology Immunopathology Immunotherapy (I3), F-75005, Paris, France; Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Hôpital Pitié-Salpêtrière, AP-HP, F-75651, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, Centre national de références Maladies Autoimmunes et systémiques rares et Maladies Autoinflammatoires rares, F-75013, Paris, France. Electronic address:

Cryoglobulinemia is defined as the persistent presence in serum of abnormal immunoglobulins (Igs) that precipitate at low temperatures and dissolve again upon warming. Cryoglobulins may be composed only of a monoclonal Ig (simple type I cryoglobulinemia), of a monoclonal Ig bound to the constant domain of polyclonal Ig heavy chains (mixed type II cryoglobulinemia), or only of polyclonal Igs (mixed type III cryoglobulinemia). The manifestations of type I cryoglobulinemia are often related to intravascular obstruction, whereas those seen in the mixed cryoglobulinemias often originate in true immune complex-mediated vasculitis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2019.01.016DOI Listing
February 2019
1 Read

Pediatric Subcutaneous Panniculitis-like T-Cell Lymphoma With Hemophagocytosis Showing Complete Resolution With the BFM90 Protocol: Case Report and Review of Literature.

J Pediatr Hematol Oncol 2019 Feb 5. Epub 2019 Feb 5.

Clinical Haematology and Bone Marrow Transplantation, Christian Medical College, Ludhiana, Punjab.

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a distinct subtype of peripheral T-cell lymphoma associated with aggressive clinical behavior. Since its original description, it has continued to be a rare disease, and <200 cases have been reported in literature. We report an 11-year-old boy who presented with SPTCL and hemophagocytic lymphohistiocytosis (HLH) and responded to high-dose multiagent chemotherapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000001434DOI Listing
February 2019
4 Reads

Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives.

Br J Haematol 2019 Feb 6. Epub 2019 Feb 6.

Division of Paediatric Haemato-Oncology, Princess Maxima Centre for Paediatric Oncology, Utrecht, The Netherlands.

The 6th International Symposium on Childhood, Adolescent and Young Adult (CAYA) Non-Hodgkin Lymphoma (NHL) was held in Rotterdam, Netherlands, 26-29 September, 2018. This summary manuscript is a perspective on the presentations from the plenary scientific sessions, including wellness and survivorship, B-cell NHL, AYA lymphoma, translational NHL biology, lymphoma immunology, bone marrow transplantation and cell therapy, T/Natural Killer cell lymphoma, anaplastic large cell lymphoma, lymphoblastic lymphoma, novel lymphoma therapeutics and Hodgkin lymphoma. The symposium was attended by over 260 registrants from 42 different countries and included young, middle and senior investigators. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15764DOI Listing
February 2019
1 Read

Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.

Acta Haematol 2019 Feb 6;141(2):119-127. Epub 2019 Feb 6.

Department of Pediatric Hematology-Oncology, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat-Gan, Israel.

Background: The WHO defined myeloid and lymphoid neoplasms (MLN) with eosinophilia associated with PDGFRB, PDGFRA, FGFR1 rearrangements as a new entity in 2016. PDGFRB-rearranged MLN sensitive to imatinib were described in adult patients. We report the first pediatric patient with PDGFRB-rearranged myeloproliferative disorder associated with T-lymphoblastic lymphoma bearing the t(5; 14)(q33;q32) translocation who was successfully treated with imatinib only. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000495687DOI Listing
February 2019
2 Reads

How useful is bone marrow study as an initial investigative tool without lymph node biopsy in malignant lymphoma?: Eleven years of experience at a single institution.

J Clin Lab Anal 2019 Feb 6:e22841. Epub 2019 Feb 6.

Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.

Background: Bone marrow (BM) study plays an important role as initial investigation specimen of lymphoma as well as staging lymphoma. This study aimed to investigate the utility of BM studies for classification of lymphoma and evaluate features of BM involvement by lymphoma over a period of 11 years.

Methods: A total of 1162 cases of BM studies for lymphoma evaluation were reviewed for the incidence of lymphoma subtypes, the percentage of marrow involvement, the pattern of involvement and discordance with histopathologic diagnoses of lymph nodes and other tissues. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcla.22841DOI Listing
February 2019

PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL.

Blood Adv 2019 Feb;3(3):360-369

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.

This study retrospectively compared long-term outcomes of nonmyeloablative/reduced intensity conditioning (NMC/RIC) allogeneic hematopoietic cell transplantation (allo-HCT) from a haploidentical family donor (haplo-HCT) using posttransplant cyclophosphamide (PTCy) with those of matched sibling donor (MSD) and matched unrelated donor (MUD) with or without T-cell depletion (TCD+/TCD-) in patients with relapsed diffuse large B-cell lymphoma (DLBCL). Adult patients with DLBCL who had undergone their first NMC/RIC allo-HCT between 2008 and 2015 were included. Recipients of haplo-HCT were limited to those receiving graft-versus-host disease (GVHD) prophylaxis with PTCy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018027748DOI Listing
February 2019
2 Reads

Failing to Make Ends Meet: The Broad Clinical Spectrum of DNA Ligase IV Deficiency. Case Series and Review of the Literature.

Front Pediatr 2018 21;6:426. Epub 2019 Jan 21.

Immunodeficiencies Research Unit at the National Institute of Pediatrics (INP), Mexico City, Mexico.

DNA repair defects are inborn errors of immunity that result in increased apoptosis and oncogenesis. DNA Ligase 4-deficient patients suffer from a wide range of clinical manifestations since early in life, including: microcephaly, dysmorphic facial features, growth failure, developmental delay, mental retardation; hip dysplasia, and other skeletal malformations; as well as a severe combined immunodeficiency, radiosensitivity, and progressive bone marrow failure; or, they may present later in life with hematological neoplasias that respond catastrophically to chemo- and radiotherapy; or, they could be asymptomatic. We describe the clinical, laboratory, and genetic features of five Mexican patients with LIG4 deficiency, together with a review of 36 other patients available in PubMed Medline. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fped.2018.00426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348249PMC
January 2019
2 Reads

BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomas.

Bone Marrow Transplant 2019 Feb 4. Epub 2019 Feb 4.

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

High-dose chemotherapy followed by autologous hematopoietic cell transplantation (AHCT) is an effective salvage therapy for patients with relapsed chemosensitive non-Hodgkin's lymphoma (NHL). However, the optimal conditioning regimen is unclear. Different conditioning regimens prior to AHCT have been used with the two most common being BEAM (carmustine, etoposide, cytarabine, and melphalan) and BUCYVP16 (busulfan, cyclophosphamide, and etoposide). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0463-yDOI Listing
February 2019

Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation.

Leuk Lymphoma 2019 Feb 4:1-9. Epub 2019 Feb 4.

a Department of Laboratory Medicine , Seoul National University College of Medicine , Seoul , Republic of Korea.

A revised WHO classification of hematopoietic neoplasm introduced the new category 'Myeloid Neoplasms with Germline Predisposition', reflecting the growing importance of genetic testing for myeloid neoplasms. Here, we investigated monozygotic twins with the same de novo mutation in GATA2 but different phenotypes. The patient suffering a bleeding tendency was diagnosed with myelodysplastic syndrome (MDS), and her monozygotic twin showed dysmegakaryopoietic features in the bone marrow. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1516039DOI Listing
February 2019
1 Read

Plasmablastic lymphoma of bone marrow: Report of a rare case and immunohistochemistry based approach to the diagnosis.

Indian J Pathol Microbiol 2019 Jan-Mar;62(1):107-110

Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Plasmablastic lymphoma (PBL) is a distinctly rare neoplasm believed to arise from post-germinal center, terminally differentiated, activated B cells before transformation to plasma cells; and predominantly affecting human immunodeficiency virus (HIV) infected or immunodeficient males. Here, we report a rare case of primary PBL of bone marrow in an immunocompetent male, the diagnosis of which is complicated by the overlapping morphology and immunophenotype with several large cell lymphomas and plasma cell neoplasms; and showing dramatic response to anti-CD30 monoclonal antibody based therapy. We discuss the immunohistochemistry based approach and the possible diagnostic pitfalls in such cases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/IJPM.IJPM_180_18DOI Listing
February 2019

Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.

Br J Haematol 2019 Jan 31. Epub 2019 Jan 31.

Division of Molecular Genetic Epidemiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.

Improvement of survival in lymphocytic leukaemia has been accompanied by the occurrence of second primary cancer (SPCs). Based on Swedish Family Cancer Database, we applied bi-directional analyses in which relative risks (RRs) were calculated for any SPCs in patients with chronic lymphocytic leukaemia (CLL), acute lymphoblastic leukaemia (ALL) and hairy cell leukaemia (HCL) and the risks of these leukaemias as SPCs. After CLL, RRs were significant for 20 SPCs, and high for skin squamous cell cancer (24·58 for in situ and 7·63 for invasive), Merkel cell carcinoma (14·36), Hodgkin lymphoma (7·16) and Kaposi sarcoma (6·76). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15777DOI Listing
January 2019
1 Read

Cardiac involvement in disseminated diffuse large B-cell lymphoma, successful management with chemotherapy dose reduction guided by cardiac imaging: A case report and review of literature.

World J Clin Cases 2019 Jan;7(2):191-202

Department of Internal Medicine, Division of Hematology/Oncology, Security Forces Hospital, Riyadh 11481, Saudi Arabia.

Background: Secondary cardiac involvement by lymphoma has received limited attention in the medical literature, despite its grave prognosis. Although chemotherapy improves patients' survival, a subgroup of treated patients dies suddenly due to myocardial rupture following chemotherapy initiation. Reducing the initial chemotherapy dose with dose escalation to standard doses may be effective in minimizing this risk but the data are limited. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12998/wjcc.v7.i2.191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354095PMC
January 2019
1 Read

IgG4-related disease: what a hematologist needs to know.

Haematologica 2019 Jan 31. Epub 2019 Jan 31.

Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, Canada.

IgG4-related disease is a fibroinflammatory condition that can affect nearly any organ system. Common presentations include major salivary and lacrimal gland enlargement, orbital disease, autoimmune pancreatitis, retroperitoneal fibrosis and tubulointerstitial nephritis. This review focuses on the hematological manifestations of IgG4-related disease, including lymphadenopathy, eosinophilia, and polyclonal hypergammaglobulinemia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.205526DOI Listing
January 2019
2 Reads

Clinicopathological Profile of Myelomatous Pleural Effusion: Single-center Real-world Experience and Review of Literature.

Clin Lymphoma Myeloma Leuk 2019 Jan 3. Epub 2019 Jan 3.

Clinical Hematology Division, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Electronic address:

Background: Multiple myeloma (MM) is a hematologic malignancy of plasma cell origin. MM primarily affects bone marrow, but extramedullary sites can also be involved. Myelomatous pleural effusion (MPE) is an atypical and rare complication of MM. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.12.003DOI Listing
January 2019
1 Read

[Prognostic study of 229 follicular lymphoma patients treated with rituximab combined with chemotherapy].

Zhonghua Xue Ye Xue Za Zhi 2019 Jan;40(1):46-51

Key Laboratory of Medical Genomics; Shanghai Institute of Hematology, Shanghai Ruijin Hospital, Shanghai 200025, China.

To explore the clinical characteristics of follicular lymphoma (FL) in the era of rituximab combined with chemotherapy and the prognostic significance of the follicular lymphoma international prognostic index (FLIPI), follicular lymphoma international prognostic index 2 (FLIPI2), international prognostic index (IPI), revised international prognostic index (R-IPI), National Comprehensive Cancer Network international prognostic index (NCCN-IPI) among Chinese patients. 229 FL patients who were treated initially with rituximab combined with CHOP-like (cyclophosphamide, doxorubicin, vincristine and prednisone) chemotherapy from November 2008 to April 2018 were analyzed retrospectively and all were scored by the above clinical index. Univariate and multivariate survival analysis were performed on 201 patients who completed the treatment and were followed regularly. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.01.009DOI Listing
January 2019
1 Read

Mucosa-associated lymphoid tissue lymphoma on right lower eyelid previously diagnosed as lymphoid hyperplasia.

Arch Craniofac Surg 2019 Feb 1. Epub 2019 Feb 1.

Department of Plastic and Reconstructive Surgery, Wonkwang University Hospital, Iksan, Korea.

Mucosa-associated lymphoid tissue (MALT) lymphoma is an uncommon form of non-Hodgkin lymphoma involving the mucosa-associated lymphoid tissue. Most commonly affected organ is the stomach. But, it could affect almost every organ in the whole body. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7181/acfs.2018.02145DOI Listing
February 2019
2 Reads

Disruption of erythroid nuclear opening and histone release in myelodysplastic syndromes.

Cancer Med 2019 Jan 30. Epub 2019 Jan 30.

Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Mammalian terminal erythropoiesis involves several characteristic phenomena including chromatin condensation and enucleation. One of the newly identified features of terminal erythropoiesis in mouse is a dynamic nuclear opening and histone release process, which is required for chromatin condensation. However, it is unclear whether the same feature is present in human. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1969DOI Listing
January 2019
3 Reads

Current development of chimeric antigen receptor T-cell therapy.

Stem Cell Investig 2018 3;5:44. Epub 2018 Dec 3.

Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China.

Chimeric antigen receptor (CAR) T-cell therapy has achieved great success in recent years, with encouraging complete remission rate and long-term durability of response, especially in advanced B-cell malignancies. With the approval of tisagenlecleucel and axi-cel by FDA to treat refractory/relapsed acute lymphoblastic leukemia and non-Hodgkin lymphoma, our understanding of CAR T cells has been progressing rapidly. In this review, we discussed the designs of CAR T cells, factors affecting response, adverse effects, as well as application beyond B-cell malignancies. Read More

View Article

Download full-text PDF

Source
http://sci.amegroups.com/article/view/22694/html
Publisher Site
http://dx.doi.org/10.21037/sci.2018.11.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327156PMC
December 2018
13 Reads

Ewing's Sarcoma and Primary Osseous Lymphoma: Spectrum of Imaging Appearances.

Semin Musculoskelet Radiol 2019 Feb 30;23(1):36-57. Epub 2019 Jan 30.

Department of Radiology, AZ Sint-Maarten Mechelen, University Hospital Antwerp, Ghent University, Mechelen, Belgium.

Ewing's sarcoma (ES) is a rare, highly malignant anaplastic stem cell tumor. Histologically, the tumor consists of uniform densely packed small monomorphic cells with round nuclei. The typical appearance at hematoxylin and eosin (H&E) staining is small blue round cells without any matrix formation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1676125DOI Listing
February 2019
3 Reads

Successful extraction of sperm cells after autologous bone marrow transplant: a case report.

Scand J Urol 2019 Jan 30:1-2. Epub 2019 Jan 30.

a Department of Urology , Herlev and Gentofte Hospital, University of Copenhagen , Herlev , Denmark.

We present a case where microdissection testicular sperm extraction (m.T.E. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21681805.2019.1570329DOI Listing
January 2019
1 Read

Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders.

Cancer Med 2019 Jan 29. Epub 2019 Jan 29.

Division of Pediatric Infectious Diseases, Washington University School of Medicine, St Louis, MO, USA.

Posttransplant lymphoproliferative disorders (PTLDs), 50%-80% of which are strongly associated with Epstein-Barr virus (EBV), carry a high morbidity and mortality. Most clinical/epidemiological/tumor characteristics do not consistently associate with worse patient survival, so our aim was to identify if other viral genomic characteristics associated better with survival. We extracted DNA from stored paraffin-embedded PTLD tissues at our center, identified viral sequences by metagenomic shotgun sequencing (MSS), and analyzed the data in relation to clinical outcomes. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cam4.1985
Publisher Site
http://dx.doi.org/10.1002/cam4.1985DOI Listing
January 2019
6 Reads

Simultaneous integrated boost with helical arc radiotherapy of total skin (HEARTS) to treat cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia - dosimetry comparison of different regimens and clinical application.

Radiat Oncol 2019 Jan 28;14(1):17. Epub 2019 Jan 28.

School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University, Taipei, Taiwan.

Background: Helical irradiation of the total skin (HITS) was modified as simultaneous integrated boost (SIB)-helical arc radiotherapy of total skin (HEARTS) technique and applied to an acute myeloid leukemia (AML) patient with disseminated leukemia cutis.

Methods: The original HITS plan was revised for different regimens, i.e. Read More

View Article

Download full-text PDF

Source
https://ro-journal.biomedcentral.com/articles/10.1186/s13014
Publisher Site
http://dx.doi.org/10.1186/s13014-019-1220-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348688PMC
January 2019
4 Reads

Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse.

Leuk Lymphoma 2019 Jan 28:1-9. Epub 2019 Jan 28.

b Department of Hematology and Bone Marrow Transplantation , Rambam Health Care Campus , Haifa , Israel.

Combination of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) is regarded as standard care for diffuse large B-cell lymphoma (DLBCL) and upfront intensification of therapy is still controversial. The current study aimed to dertermine whether the addition of high-dose methotrexate (HDMTX) affects long-term outcomes and could also prevent central nervous system (CNS) relapse. Medical records of 480 patients with DLBCL treated between 1994 and 2013 at Rambam and Hadassah medical centers in Israel were reviewed; 130 (27%) had received HDMTX. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1564823DOI Listing
January 2019
1 Read

Tumor Identification of Less Aggressive or Indolent Lymphoma With Whole-Body 11C-Acetate PET/CT.

Clin Nucl Med 2019 Jan 25. Epub 2019 Jan 25.

From the Departments of Diagnostic Radiology and Nuclear Medicine, and.

Purpose: The aim of this study was to investigate the diagnostic performance of whole-body [C]acetate PET/CT in less aggressive or indolent lymphomas, wherein [F]FDG PET/CT would exhibit limited sensitivity.

Methods: Between September 2016 and May 2018, we prospectively evaluated 17 patients (9 men, 8 women; mean age [range], 71 [45-87] years) with pathologically proven less aggressive or indolent lymphomas according to Non-Hodgkin's Lymphoma Classification Project, using both [F]FDG PET/CT and [C]acetate PET/CT (performed on the same day). Detected nodal lesions were recorded according to the Ann Arbor classification. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000002464DOI Listing
January 2019

Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse Events Using FDG-PET/CT.

Clin Nucl Med 2019 Jan 25. Epub 2019 Jan 25.

Division of Nuclear Medicine, Department of Diagnostic Radiology, Oregon Health & Science University, Portland, OR.

Purpose: To investigate whether the evaluation of tumors, lymphoid cell-rich organs, and immune-related adverse events (IRAE) with F-FDG PET/CT can predict the efficacy and outcome of immunotherapy.

Methods: Forty patients who underwent F-FDG-PET/CT scans before and after therapy with immune checkpoint inhibitors from December 2013 to December 2016 were retrospectively enrolled (malignant melanoma, n = 21; malignant lymphoma, n = 11; renal cell carcinoma, n = 8). SUVmax of the baseline and first restaging scans were evaluated in tumors, spleen, bone marrow, thyroid and pituitary glands, and were correlated to best overall response in the first year after therapy; IRAE-affected areas were also evaluated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000002453DOI Listing
January 2019
2 Reads

Molecular Testing for EGFR Mutations and ALK Rearrangements in the Cytological Specimens From the Patients With Non-Small Cell Lung Cancer.

Appl Immunohistochem Mol Morphol 2019 Feb;27(2):119-124

Department of Pathology, Indiana University School of Medicine, Indianapolis, IN.

Objective: The aim of this study was to investigate epidermal growth factor receptor (EGFR) gene mutations and anaplastic lymphoma kinase (ALK) gene rearrangements using cytological specimens from the patients with a diagnosis of primary or metastatic lung non-small cell carcinoma.

Materials And Methods: A total 307 cases were submitted for EGFR mutational analysis and 265 cases for ALK analysis. The cytological specimen sources included lung, lymph node, liver, bone, adrenal gland, mesentery mass, and body fluids/bronchial brushing. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00129039-900000000-9874
Publisher Site
http://dx.doi.org/10.1097/PAI.0000000000000701DOI Listing
February 2019
4 Reads

Divergence and heterogeneity of neoplastic PD-L1 expression: Two autopsy case reports of intravascular large B-cell lymphoma.

Pathol Int 2019 Jan 28. Epub 2019 Jan 28.

Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.

Intravascular large B-cell lymphoma (IVLBCL) is a distinct disease, but the neoplastic PD-L1 expression on tumor cells may vary among cases. We evaluated 10 IVLBCL autopsy cases for neoplastic PD-L1 expression, and had positive results in two cases. In one case, neoplastic PD-L1 expression (SP142, 28-8, and E1J2J clones) was dependent on the organ and anatomical site (capillaries vs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12757DOI Listing
January 2019
1 Read

A Novel Scoring System Based on the Level of HDL-C for Predicting the Prognosis of t-DLBCL Patients: A Single Retrospective Study.

Biomed Res Int 2018 30;2018:2891093. Epub 2018 Dec 30.

Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.

The t-DLBCL patients are generally regarded to experience a poor prognosis. However, there is little consensus to guide optimal management strategies for such patients group. The present study aimed to explore the incidence of transformation and the prognosis factors for t-DLBCL patients, thereby providing insights for clinical choices. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/2891093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330829PMC
December 2018
1 Read

G-CSF administration favours SDF-1 release and activation of neutrophils and monocytes in recipients of autologous peripheral blood progenitor cells.

Cytokine 2019 Apr 24;116:38-47. Epub 2019 Jan 24.

Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wroclaw, Poland; Department of Internal Diseases, Occupational Medicine, Hypertension and Clinical Oncology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.

G-CSF is a growth factor widely used to mobilise CD34+ progenitor cells for clinical applications. The present study aimed to assess expression of G-CSF receptor (CSF3R) on neutrophils and monocytes, as well as SDF-1 and G-CSF serum levels in relation to efficacy of G-CSF-induced mobilisation for autologous transplantation. For this purpose, 105 patients with haematological disorders and 46 healthy controls were investigated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2018.12.011DOI Listing
April 2019
6 Reads

Is True Whole-body FDG-PET/CT required in paediatric lymphoma? An IAEA Multicentre Prospective Study.

J Nucl Med 2019 Jan 25. Epub 2019 Jan 25.

International Atomic Energy Agency, Austria.

Guidelines recommend true whole body (TWB) FDG-PET/CT scans from vertex to toes in paediatric lymphoma patients, although this suggestion has not been validated in large clinical trials. The objective of the study is to evaluate the incidence and clinical impact of lesions outside the "eyes to thighs" regular field of view (R-FOV) in FDG-PET/CT staging (sPET) and interim (iPET) scans in paediatric lymphoma patients. TWB sPET and iPET scans were prospectively performed in paediatric lymphoma patients (11 worldwide centres). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.118.222299DOI Listing
January 2019
2 Reads

Palliative care service incorporated in a hematology department: a working model fostering changes in clinical practice.

Leuk Lymphoma 2019 Jan 25:1-3. Epub 2019 Jan 25.

a Department of Hematology and Bone Marrow Transplantation , Rambam Health Care Campus , Haifa , Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1564826DOI Listing
January 2019

Myeloid Sarcoma with Megakaryoblastic Differentiation Arising in the Conjunctiva.

Ocul Oncol Pathol 2019 Jan 22;5(1):28-35. Epub 2018 May 22.

Eyelid Experts, Palm Beach Gardens, Florida, USA.

An 87-year-old woman not known to have either a lymphoma or leukemia developed a left multinodular, fish-flesh superior epibulbar and forniceal mass. A biopsy disclosed a blastic tumor with scattered multinucleated immature megakaryoblasts. Immunophenotyping of bone marrow cells revealed strong positivity for CD7, CD31, CD43, CD45, CD61, and CD117; CD71, myeloperoxidase, and lysozyme were also positive in scattered cells. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/488057
Publisher Site
http://dx.doi.org/10.1159/000488057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341420PMC
January 2019
4 Reads

Intravascular large B-cell lymphoma involving large blood vessels, three autopsy cases.

Pathol Int 2019 Feb 23;69(2):97-103. Epub 2019 Jan 23.

Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.

Although intravascular large B-cell lymphoma (IVLBCL) is an extranodal lymphoma characterized by the selective growth of lymphoma cells within the lumina of small vessels, we here report three autopsy cases of IVLBCL characterized by the proliferation within large blood vessels. These three cases were diagnosed as IVLBCL of the bone marrow or skin biopsy. Two cases died suddenly before treatment, whereas the other died during treatment. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/pin.12751
Publisher Site
http://dx.doi.org/10.1111/pin.12751DOI Listing
February 2019
5 Reads

Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma.

Blood Adv 2019 Jan;3(2):187-197

Molecular Imaging and Therapy Service, Department of Radiology, and.

The prognosis of peripheral T-cell lymphoma (PTCL) is heterogenous. Baseline or interim imaging characteristics may inform risk-adapted treatment paradigms. We identified 112 patients with PTCL who were consecutively treated with cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP)/CHOP-like regimens with the intent to consolidate with an autologous transplant. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018024075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341183PMC
January 2019

Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment.

Leuk Lymphoma 2019 Jan 22:1-8. Epub 2019 Jan 22.

d CEO of Federal Government Budget Institution, National Research Center for Hematology, Ministry of Health , Moscow , Russian Federation.

We analyzed multipotent mesenchymal stromal cells (MMSCs) from the bone marrow (BM) of 33 acute myeloid leukemia (AML) patients at diagnosis, after the first course of chemotherapy (day 37), and at days 100 and 180 after diagnosis. All patients were treated according to the AML 01.10 protocol. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1554861DOI Listing
January 2019
3 Reads